Use this button to switch between dark and light mode.

Share your feedback on this Case Opinion Preview

Thank You For Submiting Feedback!

Experience a New Era in Legal Research with Free Access to Lexis+

  • Case Opinion

Motus v. Pfizer Inc.

Motus v. Pfizer Inc.

United States Court of Appeals for the Ninth Circuit

October 10, 2003, Argued and Submitted, Pasadena, California ; February 9, 2004, Filed

Nos. 02-55372, 02-55498

Opinion

 [*660]  TALLMAN, Circuit Judge:

Plaintiff Flora Motus claims that her husband suffered from an adverse reaction to the drug Zoloft, which she contends induced him to commit suicide. She argues that Pfizer Inc., as Zoloft's manufacturer, is liable because the company failed to provide adequate warnings to doctors of alleged side-effects associated with the antidepressant.  [**2]  The district court granted Pfizer's motion for summary judgment, holding that Motus failed to establish a sufficient causal link between her husband's suicide and Pfizer's conduct. See Motus v. Pfizer, Inc., 196 F. Supp. 2d 984 (C.D. Cal. 2001). Because the district court there described the facts of this case in detail we repeat only the essential ones here. Upon de novo review, see Salve Regina Coll. v. Russell, 499 U.S. 225, 231-35, 113 L. Ed. 2d 190, 111 S. Ct. 1217 (1991), we affirm. In light of our disposition, we need not reach the preemption issues raised by Pfizer on cross-appeal.

Because this is ] a diversity action, we apply California substantive law and federal rules of procedure. See Bank of California v. Opie, 663 F.2d 977, 979 (9th Cir. 1981) ] ("[In] a diversity case, federal law alone governs whether evidence is sufficient to raise a question for the trier-of-fact.") (citation omitted).

We offer no opinion on the existence of purported side-effects associated with Zoloft or on the adequacy of Pfizer's warnings. Instead, we agree with the district court that even if Pfizer's warnings concerning Zoloft and suicide were deficient,  [*661]  on [**3]  the facts of this case, Motus failed to establish that Pfizer's allegedly inadequate warnings contributed to her husband's suicide.

Motus acknowledges that Pfizer is obligated to warn doctors, not patients, of potential side-effects associated with its pharmaceutical products, see Carlin v. Superior Court, 13 Cal. 4th 1104, 1116, 56 Cal. Rptr. 2d 162, 920 P.2d 1347 (1996), and concedes that the doctor who prescribed Zoloft to her husband failed to read Pfizer's published warnings before prescribing the drug. Because the doctor testified that he did not read the warning label that accompanied Zoloft or rely on information provided by Pfizer's detail men before prescribing the drug to Mr. Motus, the adequacy of Pfizer's warnings is irrelevant to the disposition of this case.

Read The Full CaseNot a Lexis Advance subscriber? Try it out for free.

Full case includes Shepard's, Headnotes, Legal Analytics from Lex Machina, and more.

358 F.3d 659 *; 2004 U.S. App. LEXIS 1944 **; 63 Fed. R. Evid. Serv. (Callaghan) 671; CCH Prod. Liab. Rep. P16,880

FLORA MOTUS, individually, as Successor in Interest of the Estate of Victor Motus (deceased) and as Guardian Ad Litem for Lauren Motus, a minor, Plaintiff-Appellant/Cross-Appellee, v. PFIZER INC., (Roerig Division), a Corporation, Defendant-Appellee/Cross-Appellant.

Prior History:  [**1]  Appeal from the United States District Court for the Central District of California. D.C. No. CV-00-00298-AHM. A. Howard Matz, District Judge, Presiding.

Motus v. Pfizer, Inc., 196 F. Supp. 2d 984, 2001 U.S. Dist. LEXIS 24281 (C.D. Cal., 2001)

Disposition: Affirmed.

CORE TERMS

warnings, suicide, summary judgment, prescribing, district court, side-effects, accompanied, diversity, adequacy, stronger, causal

Civil Procedure, Preliminary Considerations, Federal & State Interrelationships, Erie Doctrine, General Overview, Torts, Products Liability, Types of Defects, Marketing & Warning Defects